Allscripts Takes $200m Equity Position in Nanthealth

News   Jun 30, 2015

 
Allscripts Takes $200m Equity Position in Nanthealth
 
 
 

RELATED ARTICLES

Protein "Intentionally" Terminates own Synthesis by Destabilizing Synthesis Machinery — the Ribosome

News

A research group has discovered that a protein, during its synthesis, may destabilize the structure of the ribosome and end its own synthesis prematurely, and found that this phenomenon is used for adapting the cell to its environment.

READ MORE

Dipstick Technology Enables Rapid Diagnosis Anywhere

News

A new Australian study has reported a revolutionary dipstick technology that allows DNA and RNA to be extracted from living organisms in as little as 30 seconds.

READ MORE

What’s in Your Wheat? Sequencing One of the Most Complex Genomes Known to Science

News

The wheat genome sequences may help biologists not only better understand the evolutionary history of wheat, but also advance the quest for hardier, more pest- and drought-resistant wheat types to help feed the world’s growing population.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Genomics Research Informatics & Automation Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE